- Waldencast Regains Compliance with Nasdaq Filing Requirements
- Waldencast Reports First Half 2023 Results
- Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream
- Waldencast Receives Positive Nasdaq Listing Determination
- Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors
- Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
- Waldencast Announces Participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit
- Waldencast Names Manuel Manfredi as Chief Financial Officer
- Waldencast plc Announces Fiscal Year 2022 Financial Results
- Waldencast plc Announces Receipt of Anticipated Nasdaq Delinquency Notice
More ▼
Key statistics
On Friday, Waldencast PLC (WALD:NAQ) closed at 5.10, 1.99% above its 52-week low of 5.00, set on Aug 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.34 |
---|---|
High | 5.40 |
Low | 5.04 |
Bid | 5.00 |
Offer | 6.90 |
Previous close | 5.21 |
Average volume | 95.24k |
---|---|
Shares outstanding | 122.08m |
Free float | 58.40m |
P/E (TTM) | -- |
Market cap | 622.59m USD |
EPS (TTM) | -3.40 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼